Search results
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...
Morningstar· 2 days agoThe Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo™ in select countries PRINCETON ...
Cencora Provides Notice of Data Breach Affecting Bristol Myers Squibb Customers’ Information | JD...
JD Supra· 4 days agoOn May 17, 2024, Cencora, Inc. filed a notice of data breach with the Attorney General of Massachusetts after learning that a cyberattack targeting the company’s IT network ...
Analyst Report: Bristol-Myers Squibb Company
Morningstar Research via Yahoo Finance· 18 hours agoBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus ...
Terran Biosciences prepares for trials of schizophrenia drug
Clinical Trials Arena via Yahoo Finance· 5 hours agoTerran is looking to launch two Phase I trials soon, one for each of the candidates to confirm...
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 6 days agoWe can see that institutions own the lion's share in the company with 79% ownership. That is, the...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 1 day agoIt's called targeted radiopharmaceutical therapy. RBC Capital Markets sees a $25 billion market...
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit - The Boston...
The Boston Globe· 2 days agoThe judgment was issued against Bristol Myers Squibb Company and three US-based subsidiaries of...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 1 day agoThere's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...
Pharmaceutical giant Incyte will move into two of Wilmington's most iconic buildings
Delaware Online | The News Journal via Yahoo Finance· 3 days ago“Incyte is a company with motivated leadership that is addressing complex health needs throughout...
Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
Simply Wall St. via Yahoo Finance· 1 day agoIt's only natural to consider a company's balance sheet when you examine how risky it is, since debt...